How to optimize commercialisation of innovative life science products, Dr. Kasia Hein-Peters?

Klicken Sie auf den unteren Button, um den Inhalt von zu laden.

Inhalt laden

Even though there are great accelerators and a lot of innovative product ideas, only very few products actually make it to the market and are commercially successful. What is the reason behind that and even more important how could this situation be improved?

In this podcast episode, Dr. Stefan Walzer and Dr. Kasia Hein-Peters are discussing the necessity for an overarching business and company strategy approach. In health care this is sometimes referred to a lifecycle approach, the invented approach by Dr. Kasia Hein-Peters is called DIVE. Within these approaches, all stakeholders would always need to be captured and dealt with – clinical development, regulatory and payers.

✏️ Take the chance to stay connected and subscribe with your favourite podcast platform:

#podcasthost #podcastshow #podcastepisode #marketaccess #marketaccesspodcast #reimbursement #pricingstrategy #innovation #pricing #drugs #medtech #livescience #strategy